• Login
    View Item 
    •   Home
    • The Manchester Institute Cancer Research UK
    • All Paterson Institute for Cancer Research
    • View Item
    •   Home
    • The Manchester Institute Cancer Research UK
    • All Paterson Institute for Cancer Research
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Brown, R
    Hirst, G L
    Gallagher, W M
    McIlwrath, A J
    Margison, Geoffrey P
    Van der Zee, A G
    Anthoney, D A
    Affiliation
    Department Medical Oncology, CRC Beatson Laboratories, Glasgow University, UK.
    Issue Date
    1997-07-03
    
    Metadata
    Show full item record
    Abstract
    Loss of expression of the hMLH1 and hPMS2 subunits of the MutL alpha-mismatch repair complex is a frequent event (9/10) in independent cisplatin resistant derivatives of a human ovarian carcinoma cell line. However, only hMLH1 mRNA is decreased in these MutL alpha-deficient lines. No alterations in the levels of the hMSH2 and hMSH6 (GTBP) subunits of the MutS alpha-complex are observed. An increase in the proportion of ovarian tumours negative for the hMLH1 subunit is observed in samples taken at second look laparotomy after chemotherapy (36%: 4/11), compared to untreated tumours (10%: 4/39). No significant difference is observed for hMSH2, hMSH6 or hPMS2. Furthermore, cisplatin and doxorubicin-resistant ovarian lines deficient in hMLH1 expression are cross-resistant to 6-thioguanine and the methylating agent N-methyl-N-nitrosourea (MNU). Depletion of O6-alkylguanine-DNA-alkyltransferase (ATase) activity confers only limited increased sensitivity to MNU. Thus the mismatch repair deficient lines retain DNA damage tolerance even after ATase depletion. The hMLH1 deficient lines also lose ability to engage G1 and G2 cell cycle arrest after cisplatin damage. Together these data suggest that loss of hMLH1 expression may be a high frequency event following exposure of ovarian tumour cells to cisplatin and may be critically involved in the development of drug resistance. Thus, the hMLH1 status of these cells appears to be highly correlated with the ability to engage cell death and cell cycle arrest after DNA damage induced by cisplatin.
    Citation
    hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents. 1997, 15 (1):45-52 Oncogene
    Journal
    Oncogene
    URI
    http://hdl.handle.net/10541/95253
    DOI
    10.1038/sj.onc.1201167
    PubMed ID
    9233776
    Type
    Article
    Language
    en
    ISSN
    0950-9232
    ae974a485f413a2113503eed53cd6c53
    10.1038/sj.onc.1201167
    Scopus Count
    Collections
    All Paterson Institute for Cancer Research

    entitlement

    Related articles

    • Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
    • Authors: Sergent C, Franco N, Chapusot C, Lizard-Nacol S, Isambert N, Correia M, Chauffert B
    • Issue date: 2002 Jun
    • Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells.
    • Authors: Aebi S, Fink D, Gordon R, Kim HK, Zheng H, Fink JL, Howell SB
    • Issue date: 1997 Oct
    • Modulation of drug resistance mediated by loss of mismatch repair by the DNA polymerase inhibitor aphidicolin.
    • Authors: Moreland NJ, Illand M, Kim YT, Paul J, Brown R
    • Issue date: 1999 May 1
    • Transient mismatch repair gene transfection for functional analysis of genetic hMLH1 and hMSH2 variants.
    • Authors: Brieger A, Trojan J, Raedle J, Plotz G, Zeuzem S
    • Issue date: 2002 Nov
    • Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy.
    • Authors: Samimi G, Fink D, Varki NM, Husain A, Hoskins WJ, Alberts DS, Howell SB
    • Issue date: 2000 Apr
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.